Subcutaneous Fat and the Skin

This article is for educational purposes and does not replace medical advice. Consult a healthcare provider or dermatologist for concerns specific to your skin.

The layer under your skin does more than you think

Most people picture subcutaneous fat as padding — a layer of storage between the skin and the muscle underneath. That description is not wrong, but it is incomplete. The subcutaneous layer is a working tissue. It insulates against temperature changes. It cushions against pressure. It gives the skin above it something to sit on, stretch across, and rebound over. It also communicates with the dermis directly overhead through hormones, signaling molecules, and shared blood supply [1][2].

When that layer changes quickly — which is exactly what happens on a GLP-1 medication that produces meaningful weight loss — the skin above it does not always catch up at the same pace. That mismatch is what most people are seeing when they look in the mirror during rapid weight loss and think their face looks different.

This is a reference article. Its job is to explain what the layer is, what it does, and what changes when it is lost quickly.

What subcutaneous fat is anatomically

Skin has three main layers. The epidermis is the surface layer — the part you touch and the part that holds the barrier. The dermis sits underneath and holds collagen, elastin, blood vessels, nerve endings, sweat glands, and hair follicles. Below the dermis is the subcutaneous layer, also called the hypodermis or subcutis. This is where subcutaneous fat lives.

Within that subcutaneous layer sits a further specialized compartment called dermal white adipose tissue, or dWAT. This is a thin sheet of fat cells embedded in the lower dermis and upper hypodermis, distinct in behavior from the deeper bulk of subcutaneous fat [3][4]. Researchers now recognize dWAT as its own functional tissue — not just a passive extension of body fat — with roles in temperature regulation, wound response, and innate immune defense [3][5].

The distinction matters because when weight is lost, these two adipose depots don't necessarily deflate at the same rate. Bulk subcutaneous fat responds to caloric deficit and appetite change. Dermal white adipose tissue responds to more localized signaling. Both layers thinning at once is what produces the visible skin changes people notice most.

What subcutaneous fat does

Four functions matter for how skin looks and feels.

Mechanical scaffolding. Subcutaneous fat sits under the dermis like the padding under a rug. It gives the dermis a stable surface to rest on and a substrate to stretch across when the underlying muscle moves. When the fat pad thins, the skin above it has less structural support, so it drapes across whatever contour is left underneath. On the face, this is why hollowing shows up in specific regions — the cheek fat pads, the temples, the tear troughs, the chin — rather than uniformly across the whole face. Anatomical work over the last two decades has mapped these fat pads into distinct compartments, each with its own boundaries and its own tendency to deflate [6][7].

Thermal insulation. Fat is the body's insulator. It has the lowest thermal conductance of any tissue class, which means a thicker fat layer holds warmth in and a thinner one doesn't [4]. The dWAT layer specifically has been shown to expand and contract in response to temperature, thickening in cold environments to preserve body heat [4]. During rapid weight loss, both bulk subcutaneous fat and dWAT can thin, and many people notice they feel colder in their hands, feet, and face — this is not a coincidence, and it's not imagined.

Cushioning. The subcutaneous layer absorbs mechanical force. Pressure on the skin — from a pillow, from a chair, from resting a hand against a cheek — is dispersed by the fat layer before it reaches deeper structures. When that layer thins, pressure points become more prominent, small bumps become more noticeable, and areas that used to feel soft can feel bonier. This is a normal consequence of losing fat, not a sign that something has gone wrong.

Metabolic and immune communication. Subcutaneous fat is not inert. It secretes hormones, cytokines, and signaling molecules that talk to the dermis, the immune system, and the rest of the body. dWAT in particular has been shown to release antimicrobial peptides in response to skin infection, to contribute to wound repair, and to interact with hair follicle cycling [3][5][8]. When the layer thins substantially, some of this signaling activity thins with it. Whether that shows up as visible skin change or as subtle changes in how quickly small wounds close or how the skin responds to irritation is still an active area of research.

Slow loss and rapid loss are not the same

Weight loss that happens over years gives the skin time to remodel. Collagen and elastin fibers gradually shorten and reorganize, the dermis reshapes itself to the new contour, and the visible mismatch between skin envelope and underlying volume stays small. Weight loss that happens over months, which is the pace many people see on a GLP-1, does not give the skin the same window.

A systematic review of GLP-1-associated facial changes published in Aesthetic Surgery Journal Open Forum documented the pattern clinicians are seeing across studies: reduced volume in the malar, temporal, and infraorbital regions; increased skin laxity; deepening of the nasolabial folds and marionette lines; and an overall appearance of accelerated facial aging [1]. A more recent mechanism review in the Journal of Cosmetic Dermatology described a small imaging study of five semaglutide patients that measured an average reduction of temporal fat pad volume of 41.8% and cheek fat pad volume of 69.9% [2]. Those are large numbers over a short timeframe.

The dermatology literature has emphasized a point worth repeating: this pattern is not a direct toxic effect of the medication on the skin [1][9]. It is a predictable consequence of rapid fat loss in a region where fat contributes disproportionately to visible contour. Any rapid, substantial weight loss — bariatric surgery, aggressive caloric restriction, or a GLP-1 — produces the same pattern. The medication class did not invent it; it made it more common because more people are now losing significant weight quickly.

Why age changes the outcome

The elastic recovery of skin — the ability to shrink back around a smaller underlying frame — is not the same at every age. Skin at 25 rebounds differently than skin at 45, and differently again at 60. This is a function of two things: the elastin fiber network and the collagen scaffolding that supports it.

Elastin is the protein responsible for skin's snap-back. It's produced most actively in childhood and adolescence, tapers dramatically after early adulthood, and does not regenerate meaningfully once damaged. Collagen is the protein responsible for skin's tensile strength and thickness; production declines steadily from the twenties onward. Together, the two proteins determine how much a given piece of skin can stretch and rebound.

Quantitative imaging studies of facial aging have shown that both superficial and deep facial fat compartments lose volume over time, with the deep compartments losing a larger percentage — approximately 18% over eleven years in one longitudinal analysis, compared with 11% in the superficial layer [7]. That gradual deep loss is the mechanism of what plastic surgeons call pseudoptosis: the illusion of sagging that is actually caused by deflation of the deep support layer.

When a GLP-1 or other rapid weight loss compresses years of gradual fat loss into months, the skin's elastic and collagen networks are asked to do in weeks what they normally would have had years to do gradually. In younger skin with an intact elastin network, the rebound is faster and more complete. In older skin, the mismatch between skin envelope and new underlying volume shows up more visibly and lasts longer.

This is why the same absolute amount of weight loss can produce a barely-noticeable facial change in one person and a dramatic one in another. Age of the skin, baseline elastin reserve, and pace of loss are all doing work.

The five patterns of change readers actually notice

Once you know what the layer under the skin does, the patterns readers describe start to make sense.

Hollowing in the cheeks, temples, and under-eyes is the direct signature of fat pad deflation. It shows up in specific regions rather than uniformly across the face because the fat compartments are anatomically distinct [6][7].

Laxity — skin that looks looser, drapes differently, or seems to have "more" of it — usually means the skin envelope is now sitting on top of a smaller underlying volume, not that the skin itself has stretched.

Dryness and dullness during rapid weight loss reflect several overlapping things: reduced overall fluid intake with appetite suppression, changes in circulating lipids that feed the barrier, and thinner dWAT contributing less to the microenvironment of the lower dermis.

Sensitivity — a skin that used to tolerate active ingredients now stinging or flushing — is barrier stress, and the response is the same regardless of what triggered it: strip back, protect, and rebuild before adding actives back.

Loose skin in specific regions — under the arms, along the jawline, on the abdomen — is a different phenomenon from facial hollowing. It reflects skin that has stretched past its elastic capacity over time and does not fully retract when the underlying volume drops. This is more of a mechanical story than a metabolic one.

What the evidence supports doing about it

This is a reference article, so the practical layer is short. Detail lives in the ingredient library and the spoke articles.

Protect the barrier first. A stressed, thinning subcutaneous layer often shows up as a stressed dermis and a stressed barrier. Barrier support is the foundation of every response. Read more about ceramides and occlusives here

Support collagen with evidence-backed actives. Peptides, retinoids in tolerable forms, and vitamin C in a stable formulation are the categories with the most data behind them.

Replace what's being lost through diet. Protein intake, essential fatty acids, water, and micronutrients matter more, not less, during rapid weight loss. Skin has visible thresholds for each of these.

Give the layer time to catch up. Some of the mismatch between skin envelope and underlying volume resolves as the body finds a new steady state and the skin remodels. Not all of it does — particularly in older skin with less elastin reserve — and that is where the conversation about procedural options belongs with a clinician, not with a topical routine.

When facial or skin changes on a GLP-1 mean it's time to see a clinician

Most of the changes described here are cosmetic, expected, and slow-moving. A pattern that warrants a visit is different: sudden severe volume loss over days rather than weeks, new non-healing skin, unusual reactivity or rash, signs of nutritional deficiency such as brittle hair, spoon-shaped nails, or persistent fatigue, or any change that concerns you in the context of your overall health. Facial or skin changes are sometimes the first visible sign of a nutritional or metabolic issue that belongs in a clinician's office, not in a skincare routine.

Sources

1. Daneshgaran G, Shauly O, Gould DJ. "Ozempic Face" in Plastic Surgery: A Systematic Review of the Literature on GLP-1 Receptor Agonist Mediated Weight Loss and Analysis of Public Perceptions. Aesthetic Surgery Journal Open Forum, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12232544/
2. Kruglikov IL. Mechanisms of Glucagon-Like Peptide 1 Receptor Agonist-Induced Facial Lipodystrophy and a Path Toward Prevention. Journal of Cosmetic Dermatology, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12663710/
3. Guerrero-Juarez CF, Plikus MV. Emerging non-metabolic functions of skin fat. Nature Reviews Endocrinology, 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC6042872/
4. Alexander CM, Kasza I, Yen CE, et al. Dermal white adipose tissue: a new component of the thermogenic response. Journal of Lipid Research, 2015. https://pmc.ncbi.nlm.nih.gov/articles/PMC4617393/
5. Ridha Z, Fabi SG, Zubair R, Dayan SH. Decoding the Implications of Glucagon-like Peptide-1 Receptor Agonists on Accelerated Facial and Skin Aging. Aesthetic Surgery Journal, 2024. https://academic.oup.com/asj/article/44/11/NP809/7693294
6. Wan D, Amirlak B, Rohrich R, Davis K. The Clinical Importance of the Fat Compartments in Midfacial Aging. Plastic and Reconstructive Surgery Global Open, 2014. https://pmc.ncbi.nlm.nih.gov/articles/PMC4174112/
7. Boehm LM, et al. Facial Aging: A Quantitative Analysis of Midface Volume Changes over 11 Years. Plastic and Reconstructive Surgery, 2021. https://pubmed.ncbi.nlm.nih.gov/33165293/
8. Persson C, Eaton A, Mayrovitz HN. A Closer Look at the Dermatological Profile of GLP-1 Agonists. Diseases, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12110338/
9. Cleveland Clinic. "Ozempic Face": What It Is and How to Avoid It. Cleveland Clinic Health Essentials, 2025. https://health.clevelandclinic.org/ozempic-face